Jan. 8, 2024 7:58 am ET
Boston Scientific will acquire Axonics for about $3.7 billion in cash.
The companies said on Monday that Axonics had agreed to be bought for $71 a share. Boston Scientific said the deal gave Axonics an equity value of $3.7 billion and an enterprise value of $3.4 billion.
Copyright ©2024 Dow Jones & Company, Inc. All Rights Reserved. 87990cbe856818d5eddac44c7b1cdeb8
This post first appeared on wsj.com
